Special Drug Use Investigation for PAXIL Social Anxiety Disorder (Long-term).
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Paroxetine (Primary)
- Indications Social phobia
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 01 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Jun 2013 Planned End Date changed from 1 Oct 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 22 Jun 2011 New trial record